These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34658635)

  • 21. Preliminary efficacy and tolerability profiles of first versus second-generation Long-Acting Injectable Antipsychotics in schizophrenia: A systematic review and meta-analysis.
    Saucedo Uribe E; Carranza Navarro F; Guerrero Medrano AF; García Cervantes KI; Álvarez Villalobos NA; Acuña Rocha VD; Méndez Hernández M; Millán Alanís JM; Hinojosa Cavada CM; Zúñiga Hernández JA; Fernández Zambrano SM
    J Psychiatr Res; 2020 Oct; 129():222-233. PubMed ID: 32805530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-acting injectable antipsychotics in the elderly: guidelines for effective use.
    Masand PS; Gupta S
    Drugs Aging; 2003; 20(15):1099-110. PubMed ID: 14651433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study.
    Fortea A; Ilzarbe D; Espinosa L; Solerdelcoll M; de Castro C; Oriolo G; Sugranyes G; Baeza I
    J Child Adolesc Psychopharmacol; 2018 May; 28(4):252-257. PubMed ID: 29381388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection.
    Samalin L; Charpeaud T; Lorabi O; Llorca P
    Patient Prefer Adherence; 2010 Sep; 4():325-34. PubMed ID: 20859459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of long-acting injectable risperidone in patients with bipolar I disorder: A 1-year retrospective cohort study.
    Chan HW; Huang CY; Feng WJ; Yen YC
    J Affect Disord; 2016 Nov; 205():360-364. PubMed ID: 27568173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients.
    Chowdhury D; Greer D; Liu MT; McCarthy C; Maroney M
    Ment Health Clin; 2024 Apr; 14(2):92-96. PubMed ID: 38694886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort.
    Janzen D; Bolton JM; Leong C; Kuo IF; Alessi-Severini S
    Front Pharmacol; 2022; 13():879224. PubMed ID: 35662722
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of Prescribing Patterns of Long-Acting Injectable Antipsychotics Within a Community Health System.
    Netley J; Gaul J; Ferguson C
    J Clin Psychopharmacol; 2019; 39(5):494-498. PubMed ID: 31425464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations.
    Achilla E; McCrone P
    Appl Health Econ Health Policy; 2013 Apr; 11(2):95-106. PubMed ID: 23494934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-acting injectable antipsychotics for first-episode schizophrenia: the pros and cons.
    Kim B; Lee SH; Yang YK; Park JI; Chung YC
    Schizophr Res Treatment; 2012; 2012():560836. PubMed ID: 22966439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence rates in stable bipolar disorder patients after drug discontinuation
    Kishi T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
    Psychol Med; 2021 Nov; 51(15):2721-2729. PubMed ID: 33046156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment adherence with early prescription of long-acting injectable antipsychotics in recent-onset schizophrenia.
    Viala A; Cornic F; Vacheron MN
    Schizophr Res Treatment; 2012; 2012():368687. PubMed ID: 22966435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder.
    Bobo WV; Shelton RC
    Expert Rev Neurother; 2010 Nov; 10(11):1637-58. PubMed ID: 20977322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics.
    Yan T; Greene M; Chang E; Hartry A; Touya M; Broder MS
    Curr Med Res Opin; 2018 Jan; 34(1):41-47. PubMed ID: 29057674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs).
    Brugnoli R; Rapinesi C; Kotzalidis GD; Marcellusi A; Mennini FS; De Filippis S; Carrus D; Ballerini A; Francomano A; Ducci G; Del Casale A; Girardi P
    Riv Psichiatr; 2016; 51(2):47-59. PubMed ID: 27183509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia--A 3-year follow-up.
    Liu CC; Shan JC; Chiang CL; Hsieh MH; Liu CM; Chien YL; Chen SC; Hwang TJ
    J Formos Med Assoc; 2015 Jun; 114(6):539-45. PubMed ID: 26062967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
    Tempest M; Sapin C; Beillat M; Robinson P; Treur M
    J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies.
    Bartoli F; Cavaleri D; Nasti C; Palpella D; Guzzi P; Riboldi I; Crocamo C; Pappa S; Carrà G
    Ther Adv Psychopharmacol; 2023; 13():20451253231163682. PubMed ID: 36994116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.